Appeal Court Upholds I-MED Pharma’s Patent Win Against TearLab

The Canadian Federal Court of Appeal confirmed that TearLab’s efforts to keep the I-PEN® Osmolarity System, marketed by I-MED Pharma, off the...

Read More

Key Tear Film Lipid Identified

In a finding that could signal improved treatments for dry eye, Australian identified, and then synthesized in the lab, an important component of the...

Read More

First Annual Canadian Dry Eye Summit

The first annual Canadian Dry Eye Summit (CDES) was held on May 25 -26th, 2018 at the Hotel Novotel in Mississauga, Ontario The sold out event...

Read More

NEI Study Finds Omega-3 No Better than Placebo for Dry Eye

A trial conducted by the Dry Eye Assessment and Management (DREAM) research group found that omega-3 supplements did not outperform the placebo over...

Read More

Dry Eye Disease Treatment Xiidra Approved by FDA

Shire announces that the US Food and Drug Administration (FDA) has approved Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop...

Read More